Accessibility Menu
Paradigm Medical Industries logo

Paradigm Medical Industries(OTC) PDMI

Current Price$0.00
Market Cap$3.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year-100%
1 Year-99%
1 Month+0%
Paradigm Medical Industries last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-13
Paradigm Medical Industries stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-30
1 month+0%USD 0.002026-06-11
3 month+0%USD 0.002026-03-26
Year to date+0%USD 0.002025-12-31
1 year-99%USD 0.002025-07-10
3 year+0%USD 0.002023-07-14
5 year-99.86%USD 0.002021-07-14
Since inception-100%USD 51,250.001996-07-22

Paradigm Medical Industries Financials at a Glance

Market Cap

$3.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.18M

Net Income (TTM)

-$1.47M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

11.98 (High)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

PDMI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Paradigm Medical Industries

Paradigm Medical Industries, Inc. is a U.S.-based company focused on designing, producing, and distributing advanced medical instruments primarily for diagnosing glaucoma and other ocular conditions. Established in 1989, the company offers a diverse range of ophthalmic diagnostic products from its headquarters in Salt Lake City, Utah.

Products and Services
  • Biometric analyzers and A-scans for ocular diagnostics
  • Specialized blood flow analyzers for glaucoma management
  • Software and accessories to complement medical hardware
Growth Outlook
  • Increasing demand for glaucoma diagnostic tools in the healthcare sector
  • Expansion of product offerings to meet diverse ophthalmic needs
  • Potential for strategic partnerships to enhance market reach
Financial Highlights
  • Recent quarterly revenue of 153,000, showing growth potential
  • Gross profit margin of 53.6%, indicating strong product demand
  • Operating income of 156,000, reflecting operational efficiency
Paradigm Medical Industries, Inc. operates in the medical instruments and supplies industry, specializing in innovative solutions for eye care professionals. The company's product line includes advanced biometric analyzers, A-scans, and blood flow analyzers, which are essential for diagnosing and managing glaucoma and other ocular conditions. The focus on high-quality diagnostic tools positions Paradigm to capitalize on the growing demand for eye care services. The growth outlook for Paradigm is promising, driven by an increasing need for effective glaucoma diagnostics and management solutions. The company is well-positioned to expand its product offerings and explore strategic partnerships that could enhance its market presence. Financially, Paradigm has demonstrated resilience with a recent quarterly revenue of 153,000, showcasing its ability to generate income in a competitive market. The gross profit margin of 53.6% indicates a solid demand for its products, while an operating income of 156,000 reflects operational efficiency. These financial metrics suggest that Paradigm Medical Industries, Inc. is on a path of potential growth and stability, making it an intriguing option for investors interested in the healthcare sector.
AI Generated • Jul 26, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Salt Lake City, UT 84123, US

PDMI Financials

Key Financial Metrics (TTM)

Gross Margin

68.01%

Operating Margin

42.75%

Net Income Margin

-61.40%

Return on Equity

19.31%

Return on Capital

N/A

Return on Assets

-52.96%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.25B

Volume

2

Avg. Volume

27.78K

Financials (TTM)

Gross Profit

$549.00K

Operating Income

$870.00K

EBITDA

-$858.00K

Operating Cash Flow

-$296.00K

Capital Expenditure

$0.00

Free Cash Flow

-$296.00K

Cash & ST Invst.

$44.00K

Total Debt

$1.94M

Paradigm Medical Industries Performance Analysis

Paradigm Medical Industries sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22008-06-30-7.0%
Q32008-09-30117.4%
Q42008-12-31-23.8%
Q12009-03-31-56.7%
Paradigm Medical Industries sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22008-06-306.8%
Q32008-09-3074.6%
Q42008-12-31-30.9%
Q12009-03-3192.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2009YOY CHG

Revenue

$153.00K

-33.2%

Gross Profit

$82.00K

-5.7%

Gross Margin

53.59%

N/A

Market Cap

$3.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$640.00

N/A

Employees

5

N/A

Net Income

-$282.00K

+50.2%

EBITDA

-$147.00K

+63.6%

Quarterly Fundamentals

Name
Q1 2009YOY CHG

Total Cash

$44.00K

+46.7%

Total Debt

$1.94M

-38.1%

Accounts Receivable

$111.00K

-74.1%

Inventory

$632.00K

-31.6%

Long Term Debt

$1.94M

-38.1%

Short Term Debt

$0.00

N/A

Return on Assets

-52.96%

N/A

Return on Invested Capital

-17.48%

N/A

Free Cash Flow

-$83.00K

+71.5%

Operating Cash Flow

-$83.00K

+71.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TTOOT2 Biosystems, Inc.
$0.00+0.00%
INSOIndustry Source Consulting, Inc.
$0.00+0.00%
LFCOFLift & Co. Corp.
$0.00+0.00%
MDINMedGen, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About PDMI

What is the current price of Paradigm Medical Industries?

Paradigm Medical Industries is trading at $0.00 per share.

What is the 52-week range for Paradigm Medical Industries?

Over the past 52 weeks, Paradigm Medical Industries has traded between $0.00 and $0.00.

How much debt does Paradigm Medical Industries have?

Paradigm Medical Industries total debt is unavailable.

How much cash does Paradigm Medical Industries have on hand?

Paradigm Medical Industries does not have cash on hand data available.

What is Paradigm Medical Industries’s dividend yield?

Paradigm Medical Industries does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.